Periconceptional maternal vitamin supplementation and childhood leukaemia: An uncertainty analysis

A. M. Jurek, G. Maldonado, L. G. Spector, J. A. Ross

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Background: Recent studies in childhood cancer suggest that maternal vitamin supplementation may reduce the risk of leukaemia, neuroblastoma and certain types of childhood brain tumours. For example, a previous study found a significantly reduced risk of acute lymphoblastic leukaemia (ALL) but not acute myeloid leukaemia (AML) in children with Down syndrome whose mothers reported any vitamin supplement use prior to knowledge of pregnancy (ALL OR adjusted for confounders 0.51, 95% confidence limits (CL): 0.30, 0.89; AML OR adjusted for confounders 0.92, 95% CL 0.48, 1.76). Recall of exposures, including maternal vitamin supplement use, however, may be difficult and subject to error. Epidemiologists are encouraged to quantitatively adjust for systematic error in study results, but often do not. Methods: The impact that misclassification of maternal vitamin supplement use may have had on the observed ORs in this study was quantified. Uncertainty analysis was used to calculate ORs adjusted for inaccurate reporting of vitamin supplement use under assumed probability distributions for exposure misclassification parameters. Results: Given our assumptions, adjustment for exposure misclassification yielded ORs that were predominantly more protective for ALL than the crude OR. Conclusions: Uncertainty analysis can give important insights into the magnitude and direction of error in study results due to exposure misclassification.

Original languageEnglish (US)
Pages (from-to)168-172
Number of pages5
JournalJournal of epidemiology and community health
Issue number2
StatePublished - Feb 2009


Dive into the research topics of 'Periconceptional maternal vitamin supplementation and childhood leukaemia: An uncertainty analysis'. Together they form a unique fingerprint.

Cite this